January 11, 2021

Antibe Therapeutics Provides 2021 Corporate Update

 – Large market partnering program now underway – – Limited COVID-19 impact: Phase III program slated to start in second half of 2021 – – U.S. institutional outreach expanding –  TORONTO, CANADA — (January 11, 2021) To our shareholders, As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in … Continued

read

archives

Attention

This is an external link. Click “OK” to continue.

CANCEL OK